VIRTUAL REGISTRATION: Substance Use Disorders: A Comprehensive Review and Update 2023
We invite you to join us Virtually for our Substance Use Disorders: A Comprehensive Review and Update 2023 conference!
Attend this conference virtually on substance use disorders to hear the latest research and find guidance that enhances your care for patients.
Substance use disorders are complex and have a huge impact on patients, families and communities They challenge even experienced health care professionals to stay current with evolving guidelines. And they are seen and treated across all professions, disciplines and practice settings. This includes primary care, psychiatry, social work, psychology, family practice, nursing and more.
That's why our agenda focuses on a broad update across the spectrum of substance use disorders. Sessions cover everything from neuroscience and developmental perspectives all the way through recovery-oriented systems of care. Our faculty share their experience as both clinical caregivers and research experts. They make time to answer questions and help you find solutions for complex conditions.
*PLEASE NOTE* The Buprenorphine (MAT) Waiver Training (on February 19, 2023) will not be offered virtually and can only be attended in-person.
Pricing
MDs/Doctoral-Level Professionals
Regular Registration (after January 13, 2023): $895.00
Other Professionals or Trainees
Regular Registration (after January 13, 2023): $795.00
E-SYLLABUS
We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.
Cancellation Policy
A refund minus a $100.00 administrative fee will be issued for refund requests received by January 18, 2023. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.
Massachusetts General Hospital Psychiatry Update & Board Preparation, 4th Edition
Board certification and recertification exams are critical career moments. That is why you should rely on the Massachusetts General Hospital Psychiatry Update & Board Preparation, Fourth Edition. It puts our 80+ years of clinical experience at your fingertips to help you prepare for your exam.
Target Audience
This program is intended for:
- General and Family Physicians
- Psychiatrists
- Nurse Practitioners
- Physician Assistants
- Nurses
- Psychologists
- Social Workers
Learning Objectives
Our conference lets you engage dozens of renowned clinician-researchers, get your clinical questions answered, and translate enhanced knowledge into optimal patient care.
Here are some of the ways that participants plan to change their clinical practice as a result of attending our conference:
- Describe the best practices for treatment of substance use disorders
- Discuss how to properly screen and diagnose substance use disorders
- List rational, evidence based pharmacologic and non-pharmacologic therapies for patients with substance use disorders
- Assess relative utility and strengths of recovery oriented models of care
- Assess and treat patients with co-morbid substance use, mood disorders, anxiety disorders, ADHD, pain, and infectious diseases.
- Discuss how to manage complicated withdrawal
- Utilize motivational interviewing, CBT and contingency management techniques when working with patients suffering from substance use disorders
- Describe the effects of and interventions for marijuana and synthetics
- List the different approaches and challenges associated with opioid, alcohol and nicotine treatment
- Discuss the challenges associated with identification and management of substance use disorders in the emergency department
VIRTUAL REGISTRATION: Substance Use Disorders: A Comprehensive Review and Update
February 20-22, 2023
MONDAY, FEBRUARY 20, 2023
8:00 – 8:10 AM Welcome & Introduction
David H. Rubin, MD
MODULE TOPIC 1: TREATMENT IN CONTINUING CARE
8:10 – 8:30 AM Motivational Interviewing
John F. Kelly, PhD
8:30 – 8:50 AM CBT
John F. Kelly, PhD
8:50 – 9:10 AM Helping Family Members
John F. Kelly, PhD
9:10 – 9:30 AM Screening Assessment & Patient Monitoring
Eugene Lambert, MD
9:30 – 10:10 AM Panel Discussion
Moderator: David Rubin, MD
Panelists: John F. Kelly, PhD, Eugene Lambert, MD
10:10 – 10:30 AM Coffee Break
MODULE TOPIC 2: GENERAL PRINCIPLES & CARE DELIVERY
10:30 – 10:50 AM Treating Addiction as a Chronic Disease
Jessica Gray, MD
10:50 – 11:10 AM Harm Reduction
Justin Alves, RN, MSN, ACRN, CARN, CNE
11:10 – 11:30 AM Treating Addiction in Relation to Regulatory Agencies
Laura Kehoe, MD
11:30 – 12:10 PM Panel Discussion
Moderator: John Kelly, PhD
Panelists: Jessica Gray, MD, Justin Alves, RN, MSN, ACRN, CARN, CNE
12:10 – 1:10 PM Lunch Break
MODULE TOPIC 3: RECOVERY SUPPORT SERVICES
1:10 – 1:30 PM Self-Help Treatments
John F. Kelly, PhD
1:30 – 1:50 PM Recovery Coaching & Residences
Justin Alves, RN, MSN, ACRN, CARN, CNE
1:50 – 2:10 PM Panel Discussion
Moderator: John Kelly, PhD
Panelists: Justin Alves, RN, MSN, ACRN, CARN, CNE
2:10 – 2:30 PM Coffee Break
MODULE TOPIC 4: OPIOID
2:30 – 2:50 PM Buprenorphine 101
Laura G. Kehoe, MD, MPH, FASAM
2:50 – 3:10 PM Buprenorphine: low dose inductions and extended release
Eugene Lambert, MD
3:10 – 3:30 PM Naltrexone Intramuscular & Methadone
Laura G. Kehoe, MD, MPH, FASAM
3:30 – 3:50 PM Pregnancy
Jessica Gray, MD
3:50 – 4:30 PM Panel Discussion
Moderator: Laura Kehoe, MD
Panelists: Jessica Gray, MD, Laura G. Kehoe, MD, MPH, FASAM, Eugene Lambert, MD
4:30 PM Adjourn
TUESDAY, FEBRUARY 21, 2023
8:00 – 8:10 AM Welcome & Introduction
Timothy E. Wilens, MD
MODULE TOPIC 5: NEUROSCIENCE
8:10– 8:30 AM Neurobiology of Addiction
Timothy E. Wilens, MD
8:30 - 8:50 AM Genetics of Substance Use Disorders
Robert R. Althoff, MD, PhD
8:50 – 9:10 AM Evolutionary Theories of Substance Use
David H. Rubin, MD
9:10 – 9:30 PM Coffee Break
MODULE TOPIC 6: ALCOHOL, SEDATIVES & HYPNOTICS
9:30 - 9:50 AM Alcohol
Vinod Rao, MD, PhD
9:50 – 10:10 AM Alcohol Part II
Vinod Rao, MD, PhD
10:10 – 10:30 AM Sedatives & Hypnotics
Robert R. Althoff, MD, PhD
10:30 – 10:50 AM Benzodiazepines & Addiction
Timothy Wilens, MD
10:50 – 11:10 AM Alcohol & Hepatitis
Eugene Lambert, MD
11:10 – 11:50 AM Panel Discussion
Moderator: Jessica Gray, MD,
Panelists: Vinod Rao, MD, PhD, Robert R. Althoff, MD, PhD, Timothy Wilens, MD, Eugene Lambert, MD
11:50 – 12:50 PM Lunch Break
MODULE TOPIC 7: Polysubstance Use
12:50 – 1:10 PM Fundamentals of Polysubstance Use
Timothy E. Wilens, MD
1:10 – 1:30 PM Polysubstance Use Cases
Laura G. Kehoe, MD, MPH, FASAM
1:30 – 2:10 PM Panel Discussion
Moderator: Robert R. Althoff, MD, PhD
Panelists: Timothy E. Wilens, MD, Laura G. Kehoe, MD, MPH, FASAM
2:10 – 2:30 PM Coffee Break
MODULE TOPIC 8: COMORBIDITY
2:30 – 2:50 PM Mood Disorders
Vinod Rao, MD
2:50 – 3:10 PM Pain
Jessica Gray, MD
3:10 – 3:30 PM ADHD
Timothy Wilens, MD
3:30 – 4:10 PM Panel Discussion
Moderator: Timothy Wilens, MD
Panelists: Vinod Rao, MD, Robert R. Althoff, MD, PhD, Jessica Gray, MD
4:10 PM Adjourn
WEDNESDAY, FEBRUARY 22, 2023
8:00 – 8:10 AM Welcome & Introduction
David Rubin, MD
MODULE TOPIC 9: MARIJUANA & SYNTHETICS
8:10 – 8:30 AM Marijuana 101
Timothy E. Wilens, MD
8:30 – 8:50 AM Clinical Management
Robert R. Althoff, MD, PhD
8:50 – 9:10 AM Synthetics, Kratom & Designer Drugs
Timothy E. Wilens, MD
9:10 – 9:50 AM Panel Discussion
Moderator: David Rubin, MD
Panelists: Robert R. Althoff, MD, PhD, Timothy E. Wilens, MD
9:50 – 10:10 AM Coffee Break
MODULE TOPIC 10: STIMULANTS
10:10 – 10:30 AM Inpatient Methamphetamine
Timothy E. Wilens, MD
10:30 – 10:50 AM Outpatient Methamphetamine
Justin Alves, RN, MSN, ACRN, CARN, CNE
10:50 – 11:10 AM Cocaine, Rx Stimulants
Timothy E. Wilens, MD
11:10 – 11:50 AM Panel Discussion
Moderator: Timothy Willens, MD
Panelists: Justin Alves, RN, MSN, ACRN, CARN, CNE, Timothy E. Wilens, MD
11:50 AM Adjourn
Robert R. Althoff, MD, PhD
Justin Alves, RN, MSN, ACRN, CARN, CNE
Jessica Gray, MD
Laura G. Kehoe, MD, MPH, FASAM
John F. Kelly, PhD
Eugene Lambert, MD
Vinod Rao, MD, PhD
David H. Rubin, MD
Timothy E. Wilens, MD
Available Credit
- 17.00 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this Live activity for a maximum of 17.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 17.00 Nursing Contact Hours
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 17.00 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
- 17.00 Social Workers
The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers
This program has been approved for 17.00 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D 91486
- 17.00 Participation
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.
- 17.00 Psychologists CE Credit
The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.
This offering meets the criteria for 17.00 Continuing Education (CE) credits per presentation for psychologists.